Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$59.95 - $92.06 $59 - $92
-1 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$81.07 - $121.29 $405,187 - $606,207
-4,998 Reduced 99.98%
1 $0
Q3 2021

Nov 12, 2021

BUY
$101.99 - $166.36 $505,258 - $824,147
4,954 Added 11008.89%
4,999 $581,000
Q2 2021

Aug 13, 2021

BUY
$141.6 - $179.06 $6,372 - $8,057
45 New
45 $7,000
Q2 2020

Aug 13, 2020

SELL
$89.45 - $129.85 $546,628 - $793,513
-6,111 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$70.23 - $144.31 $93,405 - $191,932
1,330 Added 27.82%
6,111 $610,000
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $365,316 - $561,958
4,781 New
4,781 $561,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.